NovaBay Pharmaceuticals, Inc.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 400.00% vs 0.00% in Sep 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 42,592.31% vs 35.00% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2.50",
          "val2": "0.50",
          "chgp": "400.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.40",
          "val2": "-1.10",
          "chgp": "63.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.10",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "557.70",
          "val2": "-0.10",
          "chgp": "5,57,800.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "552.40",
          "val2": "-1.30",
          "chgp": "42,592.31%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-156.30%",
          "val2": "-2,243.80%",
          "chgp": "208.75%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -100.00% vs -6.67% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -8,815.28% vs -18.03% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "9.80",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-7.40",
          "val2": "-4.60",
          "chgp": "-60.87%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.30",
          "val2": "0.90",
          "chgp": "-66.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-634.00",
          "val2": "0.10",
          "chgp": "-6,34,100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-641.90",
          "val2": "-7.20",
          "chgp": "-8,815.28%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "-508.50%",
          "chgp": "50.85%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Sep'25

Change(%)

Net Sales

2.50

0.50

400.00%

Operating Profit (PBDIT) excl Other Income

-0.40

-1.10

63.64%

Interest

0.00

0.10

-100.00%

Exceptional Items

557.70

-0.10

5,57,800.00%

Consolidate Net Profit

552.40

-1.30

42,592.31%

Operating Profit Margin (Excl OI)

-156.30%

-2,243.80%

208.75%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is 400.00% vs 0.00% in Sep 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is 42,592.31% vs 35.00% in Sep 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

0.00

9.80

-100.00%

Operating Profit (PBDIT) excl Other Income

-7.40

-4.60

-60.87%

Interest

0.30

0.90

-66.67%

Exceptional Items

-634.00

0.10

-6,34,100.00%

Consolidate Net Profit

-641.90

-7.20

-8,815.28%

Operating Profit Margin (Excl OI)

0.00%

-508.50%

50.85%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -100.00% vs -6.67% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -8,815.28% vs -18.03% in Dec 2024

All Annual Results